Search Results - "Pelleymounter, LL"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Pharmacogenetics of the mycophenolic acid targets inosine monophosphate dehydrogenases IMPDH1 and IMPDH2: gene sequence variation and functional genomics

    Pharmacogenetics of the mycophenolic acid targets inosine monophosphate dehydrogenases IMPDH1 and IMPDH2: gene sequence variation and functional genomics by Wu, T‐Y, Peng, Y, Pelleymounter, LL, Moon, I, Eckloff, BW, Wieben, ED, Yee, VC, Weinshilboum, RM

    Published in British journal of pharmacology (01-12-2010)
    “…BACKGROUND AND PURPOSE Inosine monophosphate dehydrogenases, encoded by IMPDH1 and IMPDH2, are targets for the important immunosuppressive drug, mycophenolic…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Gemcitabine Pharmacogenomics: Cytidine Deaminase and Deoxycytidylate Deaminase Gene Resequencing and Functional Genomics

    Gemcitabine Pharmacogenomics: Cytidine Deaminase and Deoxycytidylate Deaminase Gene Resequencing and Functional Genomics by GILBERT, Judith A, SALAVAGGIONE, Oreste E, YUAN JI, PELLEYMOUNTER, Linda L, ECKLOFF, Bruce W, WIEBEN, Eric D, AMES, Matthew M, WEINSHILBOUM, Richard M

    Published in Clinical cancer research (15-03-2006)
    “…Purpose: Gemcitabine is a nucleoside analogue with activity against solid tumors. Gemcitabine metabolic inactivation is catalyzed by cytidine deaminase (CDA)…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: